VaccineApplication · Naver

CVE-2019-13157

HIGH · 7.5 CVSS v3.1 Published 2019-11-22
Mitigation only
No fix yet — a mitigation exists. There is no fixed release. A documented workaround reduces exposure in the meantime.
See remediation →
84/100
Remediation priority · High
Remotely reachable No privileges Zero-click

Official description Straight from the sourceThe vendor's or NVD's own wording, published unedited. Authoritative, but often terse — it says what broke, rarely what to do.

NVD · unedited
nsGreen.dll in Naver Vaccine 2.1.4 allows remote attackers to overwrite arbitary files via directory traversal sequences in a filename within nsz archive.

Technical summary Written by usOur analysis, written from the advisory, the CVSS vector and the affected-version data. It adds context the advisory leaves out, and never invents facts that are not in the source.

dbcve analysis · moderate confidence

A directory traversal vulnerability exists in nsGreen.dll of Naver Vaccine 2.1.4 when processing nsz archive files. The DLL fails to properly sanitize filenames containing traversal sequences (e.g., '../'), allowing attackers to write files to arbitrary filesystem locations, potentially achieving code execution or privilege escalation.

MitigationUpdate Naver Vaccine to a patched version that properly validates and sanitizes file paths within nsz archives. Until patched, avoid opening nsz files from untrusted sources.

Verify against the referenced sources before acting — the references below are authoritative for this CVE, this summary is not.

Affected products & versions What the vendor confirmedThe version ranges the vendor confirmed as vulnerable. If your version sits inside a range here, treat yourself as exposed until you have upgraded.

NVD · CPE data
VaccineApplication
Affected:= 2.1.4

CVSS breakdown How the score is builtThe industry scoring standard. It rates how the flaw is reached, what it takes to exploit, and what an attacker gains — the score is derived from those, not the other way round.

From the vector
Attack vector
Network
Complexity
Low
Privileges
None
User interaction
None
Scope
Unchanged
Confidentiality
None
Integrity
High
Availability
None

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N

Am I affected? How to checkSteps we derive from the advisory and the affected-version data, so you can decide whether this CVE reaches your setup. They are a guide, not a scan — your own configuration is the authority.

dbcve checks

Work through these to decide whether this CVE applies to you.

  1. Check if Naver Vaccine is installed
    Look for Naver Vaccine in the installed programs list (Control Panel > Programs and Features) or search for the executable/named folder on the system
    Affected if Naver Vaccine is present on the system
  2. Verify the installed version is 2.1.4
    Right-click on the Naver Vaccine application or its executable, select Properties, and check the Version tab. Alternatively, open the application and look in Help > About
    Affected if The version is exactly 2.1.4
  3. Confirm the vulnerable DLL exists
    Locate nsGreen.dll in the Naver Vaccine installation directory, typically found in the program folder (e.g., C:\Program Files\Naver Vaccine\)
    Affected if nsGreen.dll is present in the Naver Vaccine installation folder
  4. Check for nsz archive processing activity
    Look for any recently opened or processed .nsz files on the system, or check the application's file association settings for nsz files
    Affected if The system has been used to open or process nsz archive files using Naver Vaccine 2.1.4

A system is affected only if Naver Vaccine version 2.1.4 is installed and has been used to process nsz archive files, which triggers the vulnerable code path in nsGreen.dll.

Generated from the published advisory. Verify against your own configuration.

Check your environment

Paste your version and any relevant configuration and it will be compared against the affected criteria above. Do not include secrets or credentials.

AI-assisted, checked against the advisory. Informational, not a guarantee.

Remediation Closing itWhat it takes to close this. Where a vendor fix exists we point at it; where none exists we say so plainly, and can build one. Effort estimates are scoped from the advisory, not from your codebase.

From vendor data
Mitigation available No clean upgrade yet — mitigate in the meantime
Mitigation

Update Naver Vaccine to a patched version that properly validates and sanitizes file paths within nsz archives. Until patched, avoid opening nsz files from untrusted sources.

Fix this in Vaccine Scoped from the published advisory
  • Consultation2.0 h
  • Implementation4.0 h
  • Testing6.0 h
  • Review / QA3.0 h
15.0 hours of engineering $2,560
Get help mitigating

An estimate, not a bill — we confirm scope with you before any work starts. Need it this week? Rush from $4,096.

Scan for this in your stack

Free · runs locally
dbcve dependency scanner

Check whether your project pulls in CVE-2019-13157 — or any other known-vulnerable package — straight from your lock files. Free and open source; it runs locally and uploads nothing.

References Go to the primary sourcePrimary sources — vendor advisories, patches and trackers. Where our summary and a reference disagree, the reference wins.

Primary sources

Practitioner notes

Contributed

Peer-ranked notes from engineers who’ve handled CVE-2019-13157 in production — separate from our analysis above.

No notes yet

Be the first to add a field note for this CVE — a mitigation you’ve verified, a version caveat, or a link to a working fix. Sign in above to contribute.

What this is

A place for practitioners to share what actually worked: a mitigation you’ve tested, a configuration change, a version- or environment-specific caveat, or a link to a verified patch. The most useful notes rise to the top as peers upvote them, so the signal stays high.

What belongs here
  • Verified mitigations, workarounds, and config changes
  • Version or environment caveats, and links to real fixes
  • No weaponised exploit code, or anything meant to cause harm
  • No spam, self-promotion, credentials, or personal data